Low expression of IL5RA and GDF1 contributed to the poor prognosis of children with AML, while high expression of TPM2, IL1R1, PSMD4, DHCR24, and IL12RB2 contributed to the poor prognosis of AML-afflicted children. This evidence concerns the gene TPM2 and acute myeloid leukemia.